833
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Deterrence by risk of detection? An inquiry into how elite athletes perceive the deterrent effect of the doping testing regime in their sport

Pages 206-219 | Received 01 Dec 2015, Accepted 19 Apr 2016, Published online: 01 Jul 2016

References

  • ADD. (2014). Programmer. Retrieved from http://www.antidoping.dk/om-add/programmer [accessed 10.06.2015]
  • Alaranta, A., Alaranta, H., Holmila, J., Palmu, P., Pietilä, K., & Helenius, I. (2006). Self-reported attitudes of elite athletes towards doping: Differences between type of sport. International Journal of Sports Medicine, 27, 842–846
  • Ashenden, M., Gough, C.E., Garnham, A., Gore, C.J., & Sharpe K. (2011). Current markers of the Athlete Blood Passport do not flag microdose EPO doping. European Journal of Applied Physiology, 111, 2307–2314
  • Aubel, O., & Ohl, F. (2014). An alternative approach to the prevention of doping in cycling. International Journal of Drug Policy, 25, 1094–1102
  • Backhouse, S., Collins C., Defoort, Y., McNamee, M., Parkinson, A., & Sauer, M. (2014). Study on doping prevention. A map of Legal, Regulatory and Prevention Practice Provisions in EU 28. European Commission. Luxembourg: Publications Office of the European Union. http://ec.europa.eu/sport/news/2014/docs/doping-prevention-report_en.pdf.
  • Backhouse, S.H., McKenna, J., Robinson, S., & Atkin, A. (2007). Attitudes, behaviours, knowledge and education – Drugs in sport: Past, present and future. Canada: World Anti-Doping Agency
  • Bloodworth, A., & McNamee, M. (2010). Clean Olympians? Doping and anti-doping: The views of talented young British athletes. International Journal of Drug Policy, 21, 276–282
  • Bloodworth, A.J., Petróczi, A., Bailey, R., Pearce, G., & McNamee, M.J. (2010). Doping and supplementation: The attitudes of talented young athletes. Scandinavian Journal of Medicine and Science in Sports, 22, 293–301
  • Bourdon, F., Schoch, L., Broers, B., & Kayser, B. (2015). French speaking athletes’ experience and perception regarding the whereabouts reporting system and therapeutic use exemptions. Performance Enhancement & Health, 3, 153–158
  • Bowers, L.D. (2014). The quest for clean competition in sports: Deterrence and the role of detection. Clinical Chemistry, 60, 1279–1281
  • Brissonneau, C. (2008). Doping in professional sport. Policy Department B. Structural and Cohesion Policies. European Parliament’s Committee on Culture and Education. Brussels, European Parliament
  • Brissonneau, C. (2010). An integrationist study of phenomenon of doping (1950–2010). In CERSES. Centre de Recherche Sens, Ethique, Société. Conference presentation: Body enhancements and (il)legal drugs in sport and exercise – Human and social perspectives. November 10–12, Department of Exercise and Sport Sciences, University of Copenhagen
  • Brissonneau, C., & Ohl, F. (2010). The genesis and effect of French anti-doping policies in cycling. International Journal of Sport Policy and Politics, 2, 173–187
  • Dikic, N., Markovic, S.S., & McNamee, M. (2011). On the efficacy of WADA’s whereabouts policy: Between filing failures and missed tests. Deutsche Zeitschrift für Sportmedizin, 62, 324–328
  • Dimeo, P. (2007). Beyond good and evil: A history of drug use in sport 1876–1976. New York: Routledge
  • Dölling, D., Hermann, D., Entorf, H., & Rupp, T. (2009). Is deterrence effective? Results of a meta-analysis of punishment. European Journal on Criminal Policy and Research, 15, 201–224
  • Donovan, R.J., Egger, G., Kapernick,V., & Mendoza, J. (2002). A conceptual framework for achieving performance enhancing drug compliance in sport. Sports Medicine, 32, 269–284
  • Dunn, M., Thomas, J.O., Swift, W., Burns, L., & Mattick, R.P. (2010). Drug testing in sport: The attitudes and experiences of elite athletes. International Journal of Drug Policy, 21, 330–332
  • Elbe, A.M., & Overbye, M. (2014). Urine doping controls: The athletes’ perspective. International Journal of Sport Policy and Politics, 6, 227–240
  • Elbe, A.M., & Overbye, M. (2015). Providing support for athletes with negative experiences during urine doping controls. Journal of Sport Psychology in Action, 6, 188–198
  • Engelberg,T., Moston, S., & Skinner, J. (2015). The final frontier of anti-doping: A study of athletes who have committed doping violations. Sport Management Review, 18, 268–279
  • Erickson, K., McKenna, J., & Backhouse, S. (2014). A qualitative analysis of the factors that protect athletes against doping in sport, Psychology of Sport and Exercise, 16, 149–155
  • Gucciardi, D.F., Jalleh, G., & Donovan, R.J. (2011). An examination of the Sport Drug Control Model with elite Australian athletes. Journal of Science and Medicine in Sport, 14, 469–476
  • Hanstad, D.V., & Houlihan, B. (2015). Strengthening global anti-doping policy through bilateral collaboration: The example of Norway and China. International Journal of Sport Policy and Politics, 7, 587–604
  • Hanstad, D.V., & Loland, S. (2007). Utøverundersøkelse meldeplikt. Resultater fra spørreundersøkelse. Seminar Antidoping Norge, Oslo, 3. March 2007
  • Hanstad, D.V., & Loland, S. (2009). Elite athletes’ duty to provide information on their whereabouts: justifiable anti-doping work or an indefensible surveillance system? European Journal of Sport Science, 9, 3–10
  • Hanstad, D.V., Skille, E.Å., & Loland, S. (2010). Harmonization of anti-doping work: Myth or reality? Sport in Society, 13, 418–430
  • Hauw, D., & Bilard, J. (2012). Situated activity analysis of elite track and field athletes’ use of prohibited performance-enhancing substances. The Journal of Substance Use, 17, 183–197
  • Hauw, D., & Mohamed, S. (2013). Patterns in the situated activity of substance use in the careers of elite doping athletes. Psychology of Sport and Exercise, 16, 156–163
  • Houlihan, B. (2002). Dying to win: Doping in sport and the development of anti-doping policy (2nd ed.). Strasbourg: Council of Europe Publishing
  • Houlihan, B. (2014). Achieving compliance in international anti-doping policy: An analysis of the 2009 World Anti-Doping Code. Sport Management Review, 17, 265–276
  • Huybers, T., & Mazanov, J. (2012). What would Kim do: A choice study of projected athlete doping considerations. Journal of Sport Management, 26, 322–334
  • Kayser, B., & Broers, B. (2012). ‘The Olympics and harm reduction?’ Harm Reduction Journal, 9, 1–9. doi:10.1186/1477-7517-9-33
  • Kirby, K., Moran, A., & Guerin, S. (2011). A qualitative analysis of the experiences of elite athletes who have admitted to doping for performance enhancement. International Journal of Sport Policy and Politics, 3, 205–224
  • Lucidi, F., Zelli, A., Mallia, L., Grano, C., Russo, P.M., & Violani, C. (2008). The social-cognitive mechanisms regulating adolescents’ use of doping substances. Journal of Sports Sciences, 26, 447–456
  • Lundby, C, Robach, P., & Saltin, B. (2012). The evolving science of detection of 'blood doping'. British Journal of Pharmacology, 165, 1306–1315
  • MacNamara, A., & Collins, D. (2015). Why athletes say no to doping: A qualitative exploration of the reasons underpinning athletes’ decision not to dope. Performance Enhancement & Health, 3, 145–152
  • Mazanov, J., & Huybers, T. (2010). An empirical model of athlete decisions to use performance‐enhancing drugs: qualitative evidence. Qualitative Research in Sport and Exercise, 2, 385–402
  • McNamee, M. (2010). The importance and practicality of humanistic anti doping research. Conference presentation WADA symposium, Social Science Research in Anti-Doping. November 3–5, Seoul
  • Mignon, P. (2003). The Tour de France and the doping issue. In Dauncey, H., & Hare, G. (Eds.), The Tour de France 1903–2003 (pp. 227–245). London: Cass
  • Moston, S., Engelberg, T., & Skinner, J. (2015). Athletes’ and coaches’ perceptions of deterrents to performance-enhancing drug use. International Journal of Sport Policy and Politics, 7, 623–636
  • Nagin, D.S. (1998). Criminal Deterrence Research at the Outset of the Twenty-First Century. Crime and Justice, 23, 1–42
  • Nagin, D.S., & Pogarsky, G. (2001). Integrating celerity, impulsivity, and extralegal sanction threats into a model of general deterrence: Theory and evidence, Criminology, 39, 865–892
  • Ohl, F., Fincoeur, B., Lentillon-Kaestner, V., Defrance, J., & Brissonneau, C. (2015). The socialization of young cyclists and the culture of doping. International Review for the Sociology of Sport, 50, 865–882
  • Overbye, M. (2013). Doping og anti-doping i kontekst. En analyse af eliteidrætsudøveres oplevelse af anti-doping policy, betydende faktorer for til- eller fravalg af doping, (u)lovlige præstationsfremmende midler, grænser og dilemmaer [Doping and Anti-doping in Context: An Investigation of Elite Athletes’ Experience of Anti-doping Policy, Factors that may Facilitate or Deter use of Doping, (Il)legal Performance-Enhancing Substances and Methods, Grey Zones and Dilemmas] (PhD thesis). Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark
  • Overbye, M. (2016). Doping control in sport: An investigation of how elite athletes perceive and trust the functioning of the doping testing system in their sport. Sport Management Review, 19, 6–22
  • Overbye, M., Elbe A-M., Knudsen, M., & Pfister, G. (2015). Athletes’ perceptions of anti-doping sanctions: The ban from sport versus social, financial and self-imposed sanctions. Sport in Society, 18, 364–384
  • Overbye, M., Knudsen, M., & Pfister, G. (2013). To dope or not to dope: Elite athletes’ perceptions of doping deterrents and incentives. Performance Enhancement & Health, 2, 119–134
  • Overbye, M., & Wagner, U. (2013). Between medical treatment and performance enhancement: An investigation of how elite athletes experience therapeutic use exemptions. International Journal of Drug Policy, 24, 579–588
  • Overbye, M., & Wagner, U. (2014). Experiences, attitudes and trust: An inquiry into elite athletes’ perception of the whereabouts reporting system. International Journal of Sport Policy and Politics, 3, 407–428
  • Paternoster, R. (1987). The deterrent effect of the perceived certainty and severity of punishment: A review of the evidence and issues. Justice Quarterly, 4, 173–217
  • Paternoster, R. (2010). How much do we really know about criminal deterrence? Journal of Criminal Law & Criminology, 100, 765–823
  • Paternoster, R. (2015). Perceptual deterrence and compliance with rules. Presentation at the USADA Symposium: Designing an Effective Deterrence Program. October 2-5, Lansdowne, VA
  • Pappa, E., & Kennedy, E. (2013). ‘It was my thought … he made it a reality’: Normalization and responsibility in athletes’ accounts of performance-enhancing drug use. International Review for the Sociology of Sport, 48, 277–294
  • Peters, C., Postler, T., & Oberhoffer, R. (2013). Dopingkontrollen in Deutschland. Eine Befragung von Athleten und Dopingkontrolleuren‘. Sportwissenschaft, 43, 20–33
  • Petróczi, A., & Aidman, E.V. (2008). Psychological drivers in doping: the life-cycle model of performance enhancement. Substance Abuse Treatment, Prevention, and Policy, 3, 7
  • Piffaretti, M. (2011). Psychological determinants of doping behaviour through the testimony of sanctioned athletes, WADA rapport. Lausanne: Université de Lausanne
  • Pitsch, W., & Emrich, E. (2012). The frequency of doping in elite sport: Results of a replication study. International Review for the Sociology of Sport, 47, 559–580
  • Ram, H. (2015). Stuck in the mud or going fast forward? The status of global anti-doping. Conference presentation, Play the Game conference: Global sport: reform or revolution?, October 25-29, Aarhus, Denmark. Retrieved from http://www.playthegame.org/media/4068784/26-10-Monday-1145-Herman-Ram.pdf [accessed 11.01.2016]
  • Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20, 193–201
  • Rosenkilde, N. (2015). Juraprofessor: Øget karantæne har ingen betydning. Cykelmagasinet. January 15. Retrieved from http://cykelmagasinet.dk/juraprofessor-oeget-karantaene-har-ingen-betydning [accessed 16.06.2015]
  • Rupp, T. (2008). Meta analysis of crime and deterrence: A comprehensive review of the literature. Norderstedt: Books on Demand. Retrieved from http://tuprints.ulb.tu-darmstadt.de/1054/2/rupp_diss.pdf 10 May 2013
  • Siekmann, R.C.R., & Soek, J.W. (2010). The Implementation of the WADA Code in the European Union. The Haag: T.M.C. Asser Instituut
  • Singler, A. (2011). Dopingprävention – Anspruch und Wirklichkeit. Aachen: Shaker
  • Singler, A. (2015). Doping prevention – Demands and reality. In Møller, V., Waddington, I., & Hoberman, J. (Eds.), Routledge handbook of drugs and sport (pp. 239–248). London: Routlegde
  • Stewart, B., & Smith, A.C.T. (2008). Drug use in sport: Implications for public policy. Journal of Sport & Social Issues, 32, 278–298
  • Strelan, P., & Boeckmann, R.J. (2003). A new model for understanding performance-enhancing drug use by elite athletes. Journal of Applied Sport Psychology, 15, 176–183
  • Strelan, P., & Boeckmann, R.J. (2006). Why drug testing in elite sport does not work: Perceptual deterrence theory and the role of personal moral beliefs. Journal of Applied Social Psychology, 36, 2909–2934
  • Striegel, H., Vollkommer, G., & Dickhuth, H.H. (2002). Combating drug use in competitive sport. An analysis from the athletes’ perspective. Journal of Sports Medicine and Physical Fitness, 42, 354–359
  • Striegel, H., Ulrich, R., & Simon, P. (2010). Randomised response estimates for doping and illicit drug use in elite athletes. Drug and Alcohol Dependence, 106, 230–232.
  • Thuyne, W.V., & Delbeke, F.T. (2008). Declared use of medication in sports. Clinical Journal of Sport Medicine, 18, 143–147
  • USADA. (2015). Designing an Effective Deterrence Program. USADA Science Symposium. Part I, II and III. Retrieved from http://www.usada.org/science/symposium/
  • Valkenburg, D., Hon, O., & Hilvoorde, I. (2014). Doping control, providing whereabouts and the importance of privacy for elite athletes. International Journal of Drug Policy, 25, 212–218
  • Verroken, M., & Mottram, D.R. (2005). Doping control in sport. In Mottram, D.R. (Ed.), Drugs in sport (pp. 309–356). London: Routledge
  • WADA. (2003). World Anti-Doping Code. Montreal: World Anti-Doping Agency
  • WADA. (2008). 2003 World Anti-Doping Code official report as of 31 December 2008. Retrieved from: http://www.wakoweb.com/Pdf/2384.pdf [accessed 01.02.2015]
  • WADA. (2011). Compliance Report 20 book 2011. Retrieved from: http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/The-Code/Code-Compliance-Reporting/Compliance-Report—Nov—2011/
  • WADA. (2013). Report to WADA Executive Committee on lack of effectiveness of testing programs. Montreal: World Anti-Doping Agency
  • WADA. (2014). International standard for testing and investigations. Montreal: World Anti-Doping Agency
  • WADA. (2015a). World Anti-Doping Code. Montreal: World Anti-Doping Agency
  • WADA. (2015b). 2014 Anti-Doping Testing Figures Report. Montreal: World Anti-Doping Agency
  • WADA. (2015c). Independent Commission Investigation I. Final report. Montreal: World Anti-Doping Agency
  • WADA. (2016). Independent Commission Investigation II. Final report. Montreal: World Anti-Doping Agency
  • Waddington, I., Malcolm, D., Roderick, M., & Naik, R. (2005). Drug use in English professional football. British Journal of Sports Medicine, 39, 4.e18
  • Waddington, I. & Smith, A. (2009). An introduction to drugs in sport. Addicted to winning? Oxon, UK: Routledge
  • Wagner, U. (2010). The International Cycling Union under Siege – Anti-doping and the biological passport as a mission impossible? European Sport Management Quarterly, 10, 321–342
  • Wagner, U., & Hanstad, D.V. (2011). Scandinavian perspectives on doping: A comparative policy analysis in relation to the international process of institutionalizing anti-doping. International Journal of Sport Policy, 3, 355–372
  • Wippert, M., Borucker, T., Waldenmayer, D., Schweizer, K., & Beckmann, J. (2008). Dopingprävention. Forschungsbericht (nr. 3). München: Technische Universität (unpublished)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.